(MRUS) Merus BV - Performance -2.4% in 12m
MRUS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
53.94%
#7 in Peer-Group
Rel. Strength
36.78%
#4845 in Stock-Universe
Total Return 12m
-2.40%
#64 in Peer-Group
Total Return 5y
298.98%
#6 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 62.42 USD |
| 52 Week Low | 34.89 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 68.69 |
| Buy/Sell Signal +-5 | 0.01 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MRUS (-2.4%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: MRUS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MRUS
| Total Return (including Dividends) | MRUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.00% | 3.15% | 4.01% |
| 3 Months | 29.85% | 17.08% | 17.14% |
| 12 Months | -2.40% | -11.14% | 13.46% |
| 5 Years | 298.98% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | MRUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -16% | 52.1% | 90.3% |
| 3 Months | 66.6% | 79.4% | 97.5% |
| 12 Months | -25.5% | -87.4% | 46.4% |
| 5 Years | 72.1% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th48.00 | -4.02% | -4.82% |
| 3 Month | %th63.00 | 10.91% | 10.85% |
| 12 Month | %th68.50 | 9.83% | -13.98% |
| 5 Years | %th98.50 | 411.23% | 87.55% |
FAQs
Does Merus BV (MRUS) outperform the market?
Yes,
over the last 12 months MRUS made -2.40%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months MRUS made 29.85%, while XBI made 17.08%.
Performance Comparison MRUS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MRUS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.2% | -5% | 26.8% | -16% |
| US NASDAQ 100 | QQQ | 3.3% | -5.2% | 24.8% | -16% |
| German DAX 40 | DAX | 2.8% | -2.2% | 14.7% | -33% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2% | -5.5% | 22.4% | -21% |
| Hongkong Hang Seng | HSI | 2.3% | -3.8% | 4.8% | -37% |
| India NIFTY 50 | INDA | 4.5% | -0.2% | 26.4% | 0% |
| Brasil Bovespa | EWZ | 7.4% | -0.4% | 11.8% | -4% |
MRUS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.6% | -2.7% | 23.5% | -26% |
| Consumer Discretionary | XLY | 2.3% | -4.3% | 34.5% | -21% |
| Consumer Staples | XLP | 5.2% | -0.9% | 27.8% | -10% |
| Energy | XLE | 0.2% | -5.1% | 34.4% | -4% |
| Financial | XLF | 4.6% | -3.6% | 24.5% | -28% |
| Health Care | XLV | 3% | -1.1% | 38.3% | 4% |
| Industrial | XLI | 2.8% | -5.5% | 21% | -26% |
| Materials | XLB | 2.5% | -5.5% | 26.2% | -7% |
| Real Estate | XLRE | 3.4% | -0.9% | 28.3% | -11% |
| Technology | XLK | 3.3% | -7.6% | 21.7% | -14% |
| Utilities | XLU | 3.1% | -3.6% | 22.8% | -22% |
| Aerospace & Defense | XAR | 2.5% | -7.9% | 6.8% | -51% |
| Biotech | XBI | -0.5% | -4.2% | 37.1% | 9% |
| Homebuilder | XHB | 0.1% | -9.8% | 33.4% | -1% |
| Retail | XRT | 3.3% | -4.2% | 31.7% | -9% |
MRUS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.6% | -4.30% | 40.7% | 2% |
| Natural Gas | UNG | 4.9% | 5.5% | 52.8% | -0% |
| Gold | GLD | 3.1% | -1.3% | 8.9% | -41% |
| Silver | SLV | -1.1% | -7.3% | 4.8% | -25% |
| Copper | CPER | -7.1% | -16% | 7.3% | -26% |
MRUS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.1% | -1% | 32.1% | 2% |
| iShares High Yield Corp. Bond | HYG | 3.7% | -2.1% | 29.8% | -11% |